Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Mast cells play a significant role in hair loss conditions like male pattern hair loss and alopecia areata.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Alopecia areata causes patchy hair loss and is often treated with corticosteroids.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

COVID-19 may cause hair loss due to infection stress or treatments.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

People with chronic hair loss may have a higher chance of Vitamin B12 deficiency.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

A chemical called 5-Bromo-2′-deoxyuridine caused rapid hair loss in mice by killing certain skin cells through a specific cell death pathway.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Most patients with frontal fibrosing alopecia had facial bumps, with Hispanic/Latino and premenopausal women being more affected, suggesting a more severe condition.

Some drugs can cause skin reactions, which may improve when the drug is stopped, and rapid diagnosis and stopping the drug is crucial.

A woman with lupus improved significantly from scalp hair loss after treatment, highlighting the need to identify psoriatic alopecia in lupus patients to avoid permanent hair loss.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Manipulating cell cleanup processes could help treat hair loss.

A woman lost vision in one eye after a forehead injection, but prompt treatment led to partial vision recovery.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

The document concludes that different types of hair loss have specific treatments, and early diagnosis is crucial for preventing permanent hair loss.

Some drugs can cause reversible hair loss, but certain chemotherapy drugs may lead to permanent hair loss; drugs can also change hair color and texture.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.